Goldman Sachs Upgrades Alnylam Pharmaceuticals (ALNY) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 226.79 -0.87 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $227.66 | 52 Week High | $109.10 | |||
| Open | $225.00 | 52 Week Low | $31.38 | |||
| Day High | $228.49 | P/E | N/A | |||
| Day Low | $222.82 | EPS | $-1.45 | |||
| Volume | 1,603,481 | |||||
